1.A case of a 107-year-old elderly COVID-19 patient infected with Omicron variant BA.5.1.3 in Hainan
FU Sha-sha ; WU Hai-xia ; SU Ru-kai ; ZENG Ci-mei ; WANG Jia-chong
China Tropical Medicine 2023;23(1):102-
Abstract: Objective This article summarizes the clinical characteristics and diagnosis and treatment experience of an elderly patient infected with Omicron variant BA.5.1.3 of COVID-19 in Hainan Province. Methods The clinical data and treatment of an elderly patient infected with Omicron variant BA.5.1.3 of COVID-19 admitted to Haikou designated hospital on August 15, 2022 were retrospectively analyzed. Results A 107-year-old female patient was admitted to the hospital with "fever and cough for 1 day". Two of her family members have infected with COVID-19. The patient initially developed fever, accompanied by cough, expectoration, a little white sticky sputum, accompanied by sore throat, muscle pain, fatigue. Nucleic acid test was positive in throat swab, indicating Omicron variant BA.5.1.3 infection. The patient was diagnosed as mild COVID-19 and treated with antiviral therapy, Chinese medicine conditioning, anticoagulation, electrolyte disorder regulation and symptomatic treatment for 9 days. The patient's clinical symptoms were relieved, and she was cured and discharged after two negative nucleic acid tests. One week later, the patient recovered well. Conclusions Omicron variant BA.5.1.3 is highly infectious, and comprehensive treatment such as antiviral treatment and traditional Chinese medicine treatment has achieved good efficacy. For elderly patients, attention should be paid to maintaining the stability of organ function and internal environment, which is helpful to improve the prognosis of patients.
3.A review of time-effect research on acupuncture in experimental rats/mice in the recent 10 years
Hai LU ; Jia-Hui HU ; Li-Sha HAN ; Chun-Hong ZHANG ; Yu WANG
Journal of Acupuncture and Tuina Science 2020;18(4):315-320
Objective: To summarize the influence patterns of related time factors on acupuncture effectiveness in different disease model rats/mice, and to provide reference for acupuncture clinical practice. Methods: Retrieved the relevant literatures on time-effect experimental studies of acupuncture in rats/mice in the recent 10 years. The correlations between the key time factors (such as different intervention timings of acupuncture, acupuncture moments, operation durations, needle-retaining times, intervals and treatment courses) and the acupuncture effect were analyzed and summarized. Results: From the mainstream perspective of quantification, the earlier the acupuncture intervention, the better. The proper time to implement acupuncture varied depending on disease models and points. The best operation time varied widely between different diseases. The most frequently needle-retaining time was 20-30 min. The frequency of acupuncture was usually 1 time/day; the length of the treatment course was determined according to practitioners' experience. Conclusion: Throughout the time-effect studies of acupuncture intervention in experimental rats/mice, conclusions are inconsistent, especially the lack of quantitative research on acupuncture operation time, acupuncture frequency, acupuncture treatment duration, and optimal stimulation amount. Future research should explore and determine the best time-quantity parameters that affect the effectiveness of acupuncture intervention, which is the key and goal of the acupuncture time-effect research. Independent intervention-time experiments throughout the entire course of a single disease (dominant disease) need to be done to guide clinical and disciplinary development.
4.Association study on the microRNA-1 target gene polymorphism and the risk of premature coronary artery disease
Jia-Ju ZHANG ; Li-Na WANG ; Yi FENG ; Hong ZHI ; Gen-Shan MA ; Xing-Zhou YE ; Sha-Sha QIAN ; Bei WANG
Chinese Journal of Cardiology 2012;40(5):386-391
Objective To investigate the association between the genetic variant of miRNA-1 target gene COG6 rs9548934 C→T and the risk of premature coronary artery disease (pCAD).Methods This study included 226 pACD patients and 275 gender and age matched pCAD-free controls hospitalized in our hospital,diagnosis was made based on coronary angiography ( CAG ) results.The genotypes of miRNA-1 target gene COG6 rs9548934 C→T were detected by PCR-RFLP.Results Compared with the wide genotype CC,subjects with the variant genotypes CT of rs9548934 C→T was associated with a 45% lower risk of pACD (adjusted OR =0.55,95% CI =0.36 -0.82,P =0.003),and the subjects with CT/TT genotypes were also associated with a significantly lower risk of pACD ( adjusted OR =0.64,95% CI =0.44 - 0.92,P=0.015).Using the median serum TG level (1.20 mmol/L) in control group as the cutoff value,subjects with higher serum TG levels were associated with increased risk of pACD after adjustment for age,gender and BMI ( adjusted OR =2.32,95% CI =1.57 - 3.41,P < 0.001 ).In addition,subjects with higher HDL-C levels were associated with significantly lower risk of pACD ( adjusted OR =0.48,95% CI =0.31 -0.75,P =0.001 ).Stratified analyses showed that the risk reduction for pCAD in CT/TT genotypes carriers was more significant in the female subjects ( adjusted OR =0.54,95% CI =0.30 - 0.97,P=0.040),and in subjects with lower TG,TC,HDL-C and LDL-C levels (adjusted OR =0.62,95% CI =0.39 - 0.98,P =0.040; adjusted OR =0.55,95 % CI =0.35 - 0.85,P =0.008; adjusted OR =0.43,95%CI=0.22-0.87,P=0.018; adjusted OR=0.49,95%CI=0.32-0.75,P=0.001,respectively).Conclusion The polymorphism of miRNA-1 target gene COG6 rs9548934C→T is associated with lower risk of pCAD,especially in female subjects and subjects with lower serum lipid levels.
5.Clinical efficacy of hypofractionated radiotherapy combined with immune checkpoint inhibitors in treating advanced metastatic solid tumors
Jia LIU ; Jian WANG ; Xiaowei GU ; Yiling CAI ; Jia HE ; Lingdi SUN ; Bo YU ; Zhongqin SHU ; Sha SHA
Journal of Clinical Medicine in Practice 2024;28(6):19-23
Objective To investigate the efficacy of hypofractionated radiotherapy(HFRT)com-bined with programmed cell death protein-1/programmed cell death ligand-1(PD-1/PD-L1)inhibitors in sequential with granulocyte-macrophage colony-stimulating factor(GM-CSF)and interleukin-2(IL-2)for the treatment of advanced metastatic solid tumors.Methods A prospective single-center single-arm study was designed for patients failed standard treatments for advanced refractory solid tumors in the Department of Radiotherapy of Jiangyin Hospital affiliated to Nantong University,and eli-gible patients were given quadruple therapy:HFRT(5 to 8 Gy × 2 to 3 f)once every 21 days for at least 2 cycles;200 μg GM-CSF from the 1st to 7 th day of radiotherapy,and 2 million IU IL-2 from the 8thto 14th day.Within 1 week after the completion of HFRT,PD-1/PD-L1 inhibitors were used for treatment.The above treatment strategy was repeated.GM-CSF and IL-2 were treated for 6 cycles,fol-lowed by maintenance with PD-1/PD-L1 inhibitors until disease progression(PD)or intolerable toxici-ty occurred.Objective response rate(ORR)and treatment-related adverse events were analyzed.Results From January 9,2021 to June 15,2023,totally 40 patients were enrolled,with follow-up of 2.8 to 31.0 months and a median follow-up of 9.9 months,and 39 patients(97.5%)completed at least one time tumorsite evaluation within the non-radiotherapy target area.97.5%of patients had canc-ers,2.5%had soft tissue sarcomas,and 20.0%had received immune checkpoint inhibitors(ICIs)at baseline check.The ORR was 30.8%,and the disease control rate(DCR)was 71.8%;the ORR for non-small cell lung cancer(NSCLC)was 28.6%,and the DCR was 57.1%;the ORR for colorectal cancer was 14.3%,and the DCR was 71.4%;the ORR for gastric cancer was 16.7%,and the DCR was 66.7%;28 patients(70.0%)had treatment-related adverse events(TRAE),4 patients(10%)had TRAE≥level 3,and the most common types of TRAE were fatigue,fever and hypothyroidism.Conclusion The treatment of HFRT combined with immune checkpoint inhibitors in sequential with GM-CSF and IL-2 is well tolerated and toxicity accepted in patients with advanced metastatic solid tumors,which may provide a new method for salvage treatment of patients with ad-vanced metastatic solid tumors.
6.Research progress in the molecular mechanisms and prevention strategies of ovarian injury related to cervical cancer radiotherapy
Huafang YIN ; Sha SHA ; Yiling CAI ; Bo YU ; Jia LIU ; Jia HE ; Lingdi SUN ; Jian WANG
Journal of Clinical Medicine in Practice 2024;28(10):141-144
Radiotherapy,as an important means of tumor treatment,plays a significant role in the treatment of cervical cancer.However,the ovaries are highly sensitive to radiation,which is prone to appear radiation-related injuries,leading to ovarian dysfunction and loss of fertility in young female patients,seriously affecting their physical and mental health.The degree of ovarian injury is influenced by various factors such as the dose,volume,and duration of radiation exposure to the ova-ries,as well as the patient's age.Ovarian displacement and advancements in radiotherapy techniques can significantly relieve radiation-related ovarian injury.Currently,drug protection techniques are still immature,and new fertility preservation methods are receiving increasing attention but require further improvement.This article reviewed the research progress in the molecular mechanisms,pre-vention strategies,and new fertility preservation techniques for ovarian injury related to cervical canc-er radiotherapy,aiming to provide a reference for ovarian function protection during radiotherapy for young cervical cancer patients.
7.Clinical efficacy of hypofractionated radiotherapy combined with immune checkpoint inhibitors in treating advanced metastatic solid tumors
Jia LIU ; Jian WANG ; Xiaowei GU ; Yiling CAI ; Jia HE ; Lingdi SUN ; Bo YU ; Zhongqin SHU ; Sha SHA
Journal of Clinical Medicine in Practice 2024;28(6):19-23
Objective To investigate the efficacy of hypofractionated radiotherapy(HFRT)com-bined with programmed cell death protein-1/programmed cell death ligand-1(PD-1/PD-L1)inhibitors in sequential with granulocyte-macrophage colony-stimulating factor(GM-CSF)and interleukin-2(IL-2)for the treatment of advanced metastatic solid tumors.Methods A prospective single-center single-arm study was designed for patients failed standard treatments for advanced refractory solid tumors in the Department of Radiotherapy of Jiangyin Hospital affiliated to Nantong University,and eli-gible patients were given quadruple therapy:HFRT(5 to 8 Gy × 2 to 3 f)once every 21 days for at least 2 cycles;200 μg GM-CSF from the 1st to 7 th day of radiotherapy,and 2 million IU IL-2 from the 8thto 14th day.Within 1 week after the completion of HFRT,PD-1/PD-L1 inhibitors were used for treatment.The above treatment strategy was repeated.GM-CSF and IL-2 were treated for 6 cycles,fol-lowed by maintenance with PD-1/PD-L1 inhibitors until disease progression(PD)or intolerable toxici-ty occurred.Objective response rate(ORR)and treatment-related adverse events were analyzed.Results From January 9,2021 to June 15,2023,totally 40 patients were enrolled,with follow-up of 2.8 to 31.0 months and a median follow-up of 9.9 months,and 39 patients(97.5%)completed at least one time tumorsite evaluation within the non-radiotherapy target area.97.5%of patients had canc-ers,2.5%had soft tissue sarcomas,and 20.0%had received immune checkpoint inhibitors(ICIs)at baseline check.The ORR was 30.8%,and the disease control rate(DCR)was 71.8%;the ORR for non-small cell lung cancer(NSCLC)was 28.6%,and the DCR was 57.1%;the ORR for colorectal cancer was 14.3%,and the DCR was 71.4%;the ORR for gastric cancer was 16.7%,and the DCR was 66.7%;28 patients(70.0%)had treatment-related adverse events(TRAE),4 patients(10%)had TRAE≥level 3,and the most common types of TRAE were fatigue,fever and hypothyroidism.Conclusion The treatment of HFRT combined with immune checkpoint inhibitors in sequential with GM-CSF and IL-2 is well tolerated and toxicity accepted in patients with advanced metastatic solid tumors,which may provide a new method for salvage treatment of patients with ad-vanced metastatic solid tumors.
8.Research progress in the molecular mechanisms and prevention strategies of ovarian injury related to cervical cancer radiotherapy
Huafang YIN ; Sha SHA ; Yiling CAI ; Bo YU ; Jia LIU ; Jia HE ; Lingdi SUN ; Jian WANG
Journal of Clinical Medicine in Practice 2024;28(10):141-144
Radiotherapy,as an important means of tumor treatment,plays a significant role in the treatment of cervical cancer.However,the ovaries are highly sensitive to radiation,which is prone to appear radiation-related injuries,leading to ovarian dysfunction and loss of fertility in young female patients,seriously affecting their physical and mental health.The degree of ovarian injury is influenced by various factors such as the dose,volume,and duration of radiation exposure to the ova-ries,as well as the patient's age.Ovarian displacement and advancements in radiotherapy techniques can significantly relieve radiation-related ovarian injury.Currently,drug protection techniques are still immature,and new fertility preservation methods are receiving increasing attention but require further improvement.This article reviewed the research progress in the molecular mechanisms,pre-vention strategies,and new fertility preservation techniques for ovarian injury related to cervical canc-er radiotherapy,aiming to provide a reference for ovarian function protection during radiotherapy for young cervical cancer patients.
9.Annexin A5 gene polymorphism (-1C/T) and the susceptibility to pneumoconiosis in coal works.
Ting WANG ; Sha-sha WANG ; Zhi-Guo HOU ; Xiao-Ming JI ; Zhi-Fang SONG ; Xiao-Min JIA ; Mei-Lin WANG ; Chun-Hui NI
Chinese Journal of Industrial Hygiene and Occupational Diseases 2012;30(4):246-249
OBJECTIVETo explore the role of -1C/T single nucleotide polymorphism within Annexin A5 gene in the genetic susceptibility to coal worker's pneumoconiosis (CWP).
METHODSFour hundred and seventy CWP Han chinese patients and 428 Han chinese controls were enclosed in present case-control study. All subjects were exposed to coal dusts. The polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was used to detect the -1C/T SNP in Annexin A5 gene for all subjects. The relationship between the -1C/T SNP in Annexin A5 gene and CWP was analyzed.
RESULTSCT/TT genotype in -1C/T SNP was associated with a significantly decreased risk of CWP, as compared with the CC genotype among subgroups exposed to coal dusts for ≥ 27 years (adjusted OR = 0.65, 95%CI: 0.44 - 0.98, P = 0.039) and patients with CWP at stage II (adjusted OR = 0.55, 95%CI: 0.34 - 0.90, P = 0.028).
CONCLUSIONThe results of present study suggest that the Annexin A5 -1C/T polymorphism may be involved in the development of CWP in Han Chinese coal miners.
Aged ; Annexin A5 ; genetics ; Anthracosis ; genetics ; Asian Continental Ancestry Group ; genetics ; Case-Control Studies ; Gene Frequency ; Genetic Predisposition to Disease ; Genotype ; Humans ; Male ; Middle Aged ; Polymorphism, Single Nucleotide
10.Polymorphisms in Fas pathway genes and risk of coal worker pneumoconiosis.
Sha-sha WANG ; Yang YE ; Hai-yang QIAN ; Zhi-fang SONG ; Xiao-min JIA ; Chun-hui NI
Chinese Journal of Industrial Hygiene and Occupational Diseases 2011;29(10):756-760
OBJECTIVETo explore the possible association between six single nucleotide polymorphisms (SNPs) of Fas pathway genes and the risks of coal worker pneumoconiosis (GWP).
METHODSThis case-control study consisted of 511 male patients with CWP and 530 male controls from the same coal mines. Five SNPs of Fas pathway genes were detected by restriction fragment length polymorphisms (PCR-RFLP) and CASP3 (rs6948) was genotyped by quantitative real-time polymerase chain reaction (qRT-PCR).
RESULTSThere were no differences of genotype frequencies of 6 SNPs between cases with CWP and controls. A significant increased risk of CWP was found in subjects with CASP8-652DD genotype as compared to subjects with CASP8-652II genotype (P < 0.05), and the further stratification analysis showed that smoking cases with CWP stage I, long exposure time and CASP8-652DD genotype had high risk of CWP (P < 0.05). The analysis of gene-gene interactions indicated that the carriers with FAS-1377GG/CASP8-652DD, FAS-670AG/CASP8-652DD and FASL-844CT/CASP8-652DD had the increased risk of CWP, and the carriers with FAS-1377GA/CASP8-652ID had the reduced risk of CWP. There were no significant differences of exposure times among the cases with CWP stage I and 3 genotypes of CASP8-652.
CONCLUSIONCASP8-652 6N DD genotype may play a role in CWP development and interact with SNPs of FAS-1377, FAS-670 and FASL-844.
Aged ; Aged, 80 and over ; Anthracosis ; genetics ; Case-Control Studies ; Caspase 8 ; genetics ; Genotype ; Humans ; Male ; Middle Aged ; Polymorphism, Single Nucleotide ; Risk Factors ; Signal Transduction ; fas Receptor ; genetics